PMID: 15248829Jul 14, 2004Paper

High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours

European Journal of Endocrinology
Staffan V WelinB Eriksson

Abstract

High-dose somatostatin analogue treatment has shown an antiproliferative effect in one study including patients with neuroendocrine tumours. To explore this therapeutic strategy further, we have studied the effect of a high-dose formula of octreotide, octreotide pamoate, in midgut carcinoid patients. Twelve patients with advanced midgut carcinoid tumours with a median duration of disease of more than 5 years were included. All were in a progressive state despite several previous treatment modalities. Octreotide pamoate (160 mg) was given as an intramuscular injection every 2 weeks for 2 months and then monthly. Radiological and biochemical responses were monitored. Tumour size and biochemical markers were stabilised for a median of 12 months in 75% of the patients. Ten patients had symptomatic improvement of flush and diarrhoea. In this group of patients with advanced midgut carcinoid tumours and progressive disease, octreotide pamoate managed to improve symptoms, and stabilise hormone production and tumour growth in 75% of the patients. We believe that high-dose treatment with somatostatin analogues can be an important addition to the therapeutic arsenal for patients with advanced progressive midgut carcinoid tumours.

Citations

Feb 8, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Eric E Prommer
Feb 12, 2011·Cancer Metastasis Reviews·Kjell Oberg, Daniel Castellano
Sep 27, 2006·Pituitary·Eva Tiensuu Janson
Jul 26, 2012·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Roberta Elisa RossiMaddalena Peracchi
Mar 30, 2007·Current Treatment Options in Gastroenterology·Wei Hou, Mitchell L Schubert
Feb 5, 2009·Nature Clinical Practice. Oncology·Diane L ReidyLeonard B Saltz
Oct 15, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K E Öberg
Jul 29, 2010·Pancreas·Aaron I VinikEugene A Woltering
Nov 5, 2011·Gut·John K RamageUNKNOWN UK and Ireland Neuroendocrine Tumour Society
Feb 22, 2007·Neuroendocrinology·Dermot O'TooleUNKNOWN European Neuroendocrine Tumor Society
Mar 4, 2010·Journal of Experimental & Clinical Cancer Research : CR·Marialuisa Appetecchia, Roberto Baldelli
Oct 21, 2011·International Journal of Hepatology·Theresa R HarringChristine A O'Mahony
Mar 22, 2007·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Andrew F ScarsbrookRachel R Phillips
May 16, 2008·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Priya R BhosaleJanio Szklaruk
Jul 26, 2014·Expert Opinion on Investigational Drugs·Andrea GiustinaAlfredo Berruti
Oct 22, 2009·Current Medical Research and Opinion·Lowell Anthony, Pamela U Freda
Jul 29, 2010·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Andrea FrillingUrsula Plöckinger
Sep 13, 2011·Clinical Oncology : a Journal of the Royal College of Radiologists·K E Oberg
Mar 25, 2008·Molecular and Cellular Endocrinology·Stéphane PyronnetChristiane Susini
Dec 11, 2007·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J BendelowG J Poston
Mar 27, 2007·Best Practice & Research. Clinical Endocrinology & Metabolism·U Plöckinger, B Wiedenmann
Aug 3, 2006·Surgical Oncology Clinics of North America·Rebecca S Sippel, Herbert Chen
Mar 21, 2009·Alimentary Pharmacology & Therapeutics·R SrirajaskanthanM E Caplin
Jul 4, 2009·Alimentary Pharmacology & Therapeutics·C ToumpanakisM E Caplin
Mar 3, 2007·The Journal of Pharmacy and Pharmacology·Hank S WangJoseph R Pisegna
May 25, 2011·European Journal of Clinical Investigation·Janet L Cunningham, Eva T Janson
Jul 2, 2009·International Journal of Cancer. Journal International Du Cancer·C LepageUNKNOWN EUROCARE working group
Apr 25, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Irvin M ModlinGeeta Eick
Oct 29, 2005·Best Practice & Research. Clinical Gastroenterology·W W de Herder
Oct 29, 2005·Best Practice & Research. Clinical Gastroenterology·Gerard M Doherty
Sep 27, 2005·Best Practice & Research. Clinical Gastroenterology·Julie Guillermet-GuibertChristiane Susini
Sep 27, 2005·Best Practice & Research. Clinical Gastroenterology·Tahir Shah, Martyn Caplin
Sep 23, 2008·Expert Opinion on Pharmacotherapy·I M ModlinB I Gustafsson
Apr 16, 2013·Best Practice & Research. Clinical Gastroenterology·Kjell Öberg
Nov 8, 2016·Expert Opinion on Pharmacotherapy·Angela LamarcaJuan W Valle
Oct 29, 2005·Best Practice & Research. Clinical Gastroenterology·Kjell Oberg, Barbro Eriksson
Oct 27, 2017·Expert Opinion on Pharmacotherapy·Gherardo MazziottiAndrea Giustina
Nov 14, 2007·European Journal of Gastroenterology & Hepatology·Dimitrios PapadogiasGregory Kaltsas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.